Rubella IgG

The Rubella IgG test detects specific IgG antibodies that indicate immunity against the rubella virus. This test provides evidence of past infection or vaccination and holds clinical significance particularly in evaluating immunity status before pregnancy.

Measuring Rubella IgG levels helps assess the adequacy of protective antibodies, supporting immunity monitoring. This measurement contributes to screening in high-risk occupational groups, verifying vaccine response, and monitoring community immunity.

Rubella immunity assessment is used to confirm seroconversion after vaccination. The presence of IgG indicates long-term protection and helps prevent rubella-related complications, particularly in women of reproductive age.

Rubella serologic monitoring identifies susceptible individuals and supports prevention of potential outbreaks. This approach contributes to risk management in public health programs and enables effective implementation of targeted vaccination strategies.

What Is Rubella IgG?

Rubella IgG is an antibody that indicates whether immunity has developed against the rubella virus. This antibody shows that the person has either had rubella before or has been vaccinated and has developed immunity to the disease. It is particularly important in pre-pregnancy screening, as active infection can lead to a significant risk of congenital anomalies in the fetus. A positive Rubella IgG result indicates protective immunity.

What is rubella and why is it so important for pregnancy planning?

Rubella is a viral disease that usually presents with rash, mild fever, and fatigue. When contracted in childhood or adulthood, it is often extremely mild, even resembling a simple cold. However, this seemingly “innocent” illness reveals a completely different face when pregnancy is involved.

If a woman encounters this virus for the first time during pregnancy (especially in the early months), the consequences for the unborn baby can be devastating. The virus can pass from the mother to the baby and cause a condition called “Congenital Rubella Syndrome” (CRS), which results in permanent and severe organ damage in the baby. Our primary goal in pregnancy planning, especially in IVF treatment, is to prevent this tragedy with 100% certainty. Therefore, determining every prospective mother’s rubella immunity status before starting treatment is not a suggestion but an obligation.

Why do many people not remember or notice having had rubella?

This is one of rubella’s most dangerous and insidious aspects. Approximately half (50%) of adult rubella infections present with no symptoms. The person may feel only mild fatigue, without rash or noticeable illness. This is particularly risky for pregnant women. A person may unknowingly contract the virus and transmit it to the baby.

Statements such as “I think I had it as a child” or “I don’t remember ever having it” are not reliable for medical decisions. The only scientifically reliable way to know immunity status is through a laboratory blood test.

What does contracting rubella during pregnancy do to the baby?

When a pregnant woman acquires the virus, it enters the bloodstream and easily crosses the placenta, reaching the developing baby. The virus attacks the baby’s cells during the most sensitive period when organs are forming. This attack can halt or disrupt normal development.

Consequences vary depending on the gestational week in which the infection occurs and may result in miscarriage, stillbirth, or lifelong disabilities in the baby.

What is Congenital Rubella Syndrome (CRS) and what defects does rubella cause?

Congenital Rubella Syndrome (CRS) consists of permanent birth defects seen in babies exposed to the virus in the womb. Different complications arise depending on the organ affected. The most common and “classic triad” of defects are:

• Severe hearing loss (deafness)
• Cataract (clouding of the eye lens)
• Congenital heart defects

Beyond these main issues, the virus may also cause:

• Intellectual and developmental delay
• Microcephaly (small head size)
• Brain and meningeal inflammation
• Enlargement of the liver and spleen
• Low birth weight
• Bone marrow problems

The most tragic aspect of this syndrome is that once it develops, there is no specific treatment. After birth, medical care focuses only on managing complications. Therefore, the only solution is prevention—ensuring maternal immunity before pregnancy begins.

Which period of pregnancy is the riskiest for rubella?

The first trimester (first 12 weeks), when the baby’s organs form, is the “red zone” of highest danger. If a woman contracts rubella during the first 12 weeks, the risk of fetal infection and CRS is an alarming 90%.

The risk decreases rapidly as pregnancy progresses.

• First 8–10 Weeks: Risk around 90% (most dangerous period).
• 11–16 Weeks: Risk drops to 10–20%.
• 16–20 Weeks: Risk is much lower, though isolated defects like hearing loss have been reported.
• After Week 20: CRS risk becomes extremely low.

This clearly demonstrates why immunity must be ensured before pregnancy—intervention is no longer possible once pregnancy begins.

Why is the rubella test (Rubella IgG) mandatory before IVF treatment?

IVF treatment is a carefully planned process requiring significant emotional, physical, and financial investment. The goal is to eliminate all preventable risks to ensure a healthy pregnancy.

Rubella is a vaccine-preventable disease with 100% preventability. Identifying non-immune women before pregnancy and vaccinating them serves as insurance for treatment success and the baby’s health. Performing embryo transfer without knowing the mother’s immunity status is an unacceptable risk.

What do the letters “IgG” and “IgM” in my blood test mean?

When the body encounters a virus or vaccine, it produces special proteins called antibodies. Rubella serology evaluates two types:

• IgM (Immunoglobulin M): These are the “emergency response team.” They are the first antibodies produced in a new infection. Their presence indicates active or very recent infection. They usually disappear within weeks or months.
• IgG (Immunoglobulin G): These are the “memory” antibodies. They appear shortly after IgM and provide long-term, often lifelong immunity. Their presence indicates past infection or vaccination and protection against future infection.

Why is only the Rubella IgG test checked when planning pregnancy?

If the patient has no symptoms (rash, fever, etc.), only the Rubella IgG test is evaluated before pregnancy or IVF. The only concern is whether the body has long-term “memory” (IgG).

IgM testing is not routinely requested because of its relatively high false-positive rate. A person may appear IgM positive due to other viral infections or rheumatologic factors, causing false alarm and unnecessary delays. Therefore, in healthy, asymptomatic women, IgG alone is sufficient.

How is my Rubella IgG test result interpreted?

The Rubella IgG test is quantitative and reported in IU/mL (International Units per milliliter). The magic number is 10 IU/mL.

• 10 IU/mL or above (≥10): Protective immunity present.
• Below 10 IU/mL (<10): No or insufficient protection.

Laboratory reports also often include comments such as “Positive,” “Negative,” or “Equivocal.”

What does a “Positive” (Immune) result mean?

This is the “good news.” A positive or reactive result generally indicates an IgG value above 10 IU/mL and a strong immune memory. This means previous infection or vaccination.

Next steps:

• No further testing or action is required.
• You are considered protected against rubella.
• IVF or pregnancy planning may continue without delay.

This immunity protects both mother and baby even if exposed during pregnancy.

What does a “Negative” (Non-immune) result mean?

It means you are susceptible. IgG values usually appear as <10 IU/mL (sometimes 0 or 1).

This result indicates:

• You have not had rubella.
• You have not been vaccinated or previous vaccination did not work.
• You are completely unprotected if exposed.
• This requires urgent action before pregnancy.

What does a “Borderline” (Equivocal) result mean and what should be done?

This is the most confusing result but management is straightforward. “Borderline” indicates IgG is slightly below 10 IU/mL (e.g., 5.00–9.99 IU/mL).

Immunity cannot be guaranteed. In IVF, ambiguity is unacceptable. Therefore, a borderline result is treated like a negative result. Repeating the test later often only wastes time. The safest approach is vaccination.

What is the treatment plan if my Rubella IgG result is Negative or Borderline?

When immunity is insufficient (Negative or Borderline), the IVF timeline is temporarily adjusted.

Steps:

• Vaccination: One dose of MMR (Measles-Mumps-Rubella) is given.
• Pregnancy Test: Performed right before vaccination to confirm the patient is not pregnant.
• Mandatory Waiting: After the vaccine, at least 28 days must pass before pregnancy or embryo transfer.
• Start Treatment: After 28 days, pregnancy planning or IVF transfer can safely begin.

Why must I wait 28 days after the MMR vaccine?

The MMR vaccine is a live attenuated vaccine. The waiting period ensures no theoretical transmission to the fetus and allows a strong immune response to develop.

Reasons:

• To allow clearance of vaccine virus from the body.
• To allow robust IgG immunity to develop.

How does this 28-day waiting period affect IVF treatment?

Because IVF is planned, the waiting period rarely causes significant delay.

Scenarios:
Yolk Retrieval (OPU): Vaccination is often done right after OPU. Embryos are frozen while the patient completes the 28-day waiting period. Next cycle, endometrial preparation begins for frozen embryo transfer.

Frozen Embryo Transfer (FET): If embryos are already frozen, vaccination is done before starting estrogen. After 28 days, preparation resumes.

What happens if my Rubella IgG test is still negative despite vaccination?

This is rare and occurs in about 1–5% of people. Known as “vaccine non-responsiveness,” the body does not produce sufficient antibodies (≥10 IU/mL) after the first dose.

Management:

• A second dose of MMR is administered at least 28 days after the first dose.
• This second dose is not a booster but an attempt to induce response in non-responders.
• Rubella IgG is rechecked 6–8 weeks after the second dose. Most respond.

What if immunity still doesn’t develop after two doses (Permanent Non-Responder)?

Very rarely, some remain Negative or Borderline even after two doses. These individuals are “permanent vaccine non-responders.” A third dose is usually not given.

Management shifts to risk avoidance:

• Patient is considered permanently susceptible.
• Comprehensive counseling is provided.
• Avoidance of exposure during pregnancy (especially first 20 weeks) is emphasized.
• Avoid contact with people with fever or rash illnesses.

Most importantly, a “cocoon strategy” is used, ensuring all close contacts are fully vaccinated.

Can rubella immunity decrease over time? I was vaccinated years ago—should I retest?

Yes, this is possible. While MMR immunity is long-lasting, IgG levels may slowly decline. Even if immune years ago, today’s test may show a borderline level (e.g., 8 IU/mL). We must follow current lab results.

Thus, the safest approach is to recheck IgG before pregnancy planning. If borderline, a booster (plus 28-day wait) ensures protective immunity.

Why is this rubella protocol applied so strictly?

Rubella screening, vaccination, and the 28-day waiting rule are universal standards endorsed by CDC, ASRM, WHO, and other authorities.

The goal is singular: preventing Congenital Rubella Syndrome (CRS) with 100% certainty. This simple test and vaccine are among the most important safety steps in achieving a healthy pregnancy through IVF.

Frequently Asked Questions